デフォルト表紙
市場調査レポート
商品コード
1673605

腸溶性ソフトジェルの市場規模、シェア、成長分析:製品タイプ別、原材料別、流通チャネル別、用途別、エンドユーザー別、地域別 - 産業予測 2025~2032年

Enteric Softgel Market Size, Share, and Growth Analysis, By Product Type (Gelatin Softgel Capsules, Vegetarian Softgel Capsules), By Raw Material, By Distribution Channel, By Application, By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
腸溶性ソフトジェルの市場規模、シェア、成長分析:製品タイプ別、原材料別、流通チャネル別、用途別、エンドユーザー別、地域別 - 産業予測 2025~2032年
出版日: 2025年03月03日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

腸溶性ソフトジェルの世界市場規模は、2023年に24億米ドルと評価され、2024年の25億米ドルから2032年には34億5,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは4.1%で成長する見通しです。

腸溶性ソフトジェルカプセルの市場は、半固形および液体薬用のゼラチンベースのコーティングを特徴とし、予防医学の利点に対する消費者の意識の高まり、高齢者人口の増加、慢性疾患や栄養欠乏症の蔓延によって、大きな成長が見込まれています。健康意識が高まるにつれて栄養補助食品も受け入れられ、需要をさらに促進しています。注目すべきは、菜食主義の消費者に対応する革新的な非ゼラチン製品が出現していることで、デンプンや植物由来の原料を利用して市場の魅力を高めています。さらに、eコマースプラットフォームの拡大や、カプセルの生物学的利用能の向上を目指した大手企業による研究開発投資の活発化は、市場力学にプラスの影響を与えそうです。摂取に水を必要としないチュアブルソフトジェルの選択肢は、今後数年間で市場の見通しを押し上げると予想されます。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制情勢
  • ケーススタディ
  • 技術の進歩

腸溶性ソフトジェル市場規模:製品タイプ別& CAGR(2025-2032)

  • 市場概要
  • ゼラチンソフトジェルカプセル
  • ベジタリアンソフトジェルカプセル

腸溶性ソフトジェル市場規模:原材料別& CAGR(2025-2032)

  • 市場概要
  • A型ゼラチン(豚皮)
  • B型ゼラチン(動物の骨と皮)
  • 魚骨ゼラチン
  • セルロース誘導体
  • デンプン質材料

腸溶性ソフトジェル市場規模:流通チャネル別& CAGR(2025-2032)

  • 市場概要
  • スーパーマーケットとハイパーマーケット
  • 薬局・ドラッグストア
  • オンラインプロバイダー

腸溶性ソフトジェル市場規模:用途別& CAGR(2025-2032)

  • 市場概要
  • 制酸剤および整腸剤
  • 抗炎症薬
  • 抗生物質および抗菌薬
  • 咳と風邪の対策
  • 健康サプリメント
  • ビタミンと栄養補助食品
  • その他の治療用途

腸溶性ソフトジェル市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 製薬会社
  • 栄養補助食品会社
  • 化粧品会社
  • 食品産業

腸溶性ソフトジェル市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • BASF SE(Germany)
  • Colorcon Inc.(United States)
  • Fuji Capsule Co., Ltd.(Japan)
  • Lonza Group AG(Switzerland)
  • Now Health Group Inc.(United States)
  • ProCaps Group(Luxembourg)
  • Super Spectrim(United States)
  • Thermo Fisher Scientific Inc.(United States)
  • Key Developments
  • Sirio Pharma Co., Ltd.(China)
  • Soft Gel Technologies, Inc.(United States)
  • EuroCaps Ltd.(United Kingdom)
  • Geltec Pvt. Ltd.(India)
  • Captek Softgel International, Inc.(United States)
  • Elnova Pharma(Canada)
  • Best Formulations(United States)
  • Pharmavite LLC(United States)
  • Robinson Pharma, Inc.(United States)

結論と提言

目次
Product Code: SQMIG35I2240

Global Enteric Softgel Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.5 billion in 2024 to USD 3.45 billion by 2032, growing at a CAGR of 4.1% during the forecast period (2025-2032).

The market for enteric softgel capsules, which feature gelatin-based coatings for semi-solid and liquid medications, is poised for significant growth, driven by increasing consumer awareness of preventive medicine benefits, a rising geriatric population, and the prevalence of chronic and nutrient deficiency diseases. As health consciousness grows, so does the acceptance of dietary supplements, further fueling demand. Notably, innovative non-gelatin variants catering to vegan consumers are emerging, utilizing starch and plant-based sources to enhance market appeal. Additionally, the expansion of e-commerce platforms and heightened R&D investments by major players aimed at improving capsule bioavailability are set to positively influence market dynamics. Chewable softgel options that require no water to consume are anticipated to boost market prospects in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enteric Softgel market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Enteric Softgel Market Segments Analysis

Global Enteric Softgel Market is segmented by Product Type, Raw Material, Distribution Channel, Application, End User and region. Based on Product Type, the market is segmented into Gelatin Softgel Capsules and Vegetarian Softgel Capsules. Based on Raw Material, the market is segmented into Type-A Gelatin (Pork Skin), Type-B Gelatin (Animal Bones and Skin), Fish Bone Gelatin, Cellulose Derivatives and Starch Material. Based on Distribution Channel, the market is segmented into Supermarket and Hypermarket, Pharmacy and Drug store and Online Provider. Based on Application, the market is segmented into Antacid and Antiflatulent Preparations, Anti-inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplements, Vitamin and Dietary Supplements and Other Therapeutic Applications. Based on End User, the market is segmented into Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Food Industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Enteric Softgel Market

The global enteric softgel market is primarily driven by a surge in investments aimed at enhancing the bioavailability of these capsules. Notably, leading companies are ramping up production to satisfy the growing demand for health-focused nutritional supplements. For instance, Catalent Pharma Solutions, a prominent American player, recently announced plans to invest over USD 5 million in a new drug development center located in Somerset, New Jersey. This investment is expected to bolster the company's capabilities in capsule coating technology, thereby strengthening its position within the enteric softgel market. As advanced manufacturing techniques are developed and major players focus on improving efficiency, the market is set to witness increased productivity and reduced complexity in drug development processes.

Restraints in the Global Enteric Softgel Market

The global enteric softgel market faces significant challenges related to the stability and shelf-life of these capsules. Consumers often encounter issues when storing enteric softgels for more than six months, leading to concerns about their efficacy. Moreover, the inherent dynamic nature of these capsules complicates efforts for manufacturers to enhance both their shelf-life and chemical stability. As a result, this limitation can hinder widespread adoption and consumer confidence in enteric softgel products, posing a notable restraint on market growth and innovation. Addressing these stability issues will be crucial for advancing the market potential of enteric softgel capsules.

Market Trends of the Global Enteric Softgel Market

The Global Enteric Softgel market is experiencing a notable shift towards vegan alternatives, driven by the rising trend of veganism and growing consumer awareness regarding animal welfare and health impacts associated with traditional gelatin-based capsules. As more consumers adopt vegetarian and vegan lifestyles, demand for plant-based enteric softgel options is expected to increase significantly. This paradigm shift is compelling manufacturers to innovate and reformulate products, utilizing ingredients such as hydroxypropyl methylcellulose and other plant-derived substances. Market dynamics are thus evolving, with a focus on sustainability and health-conscious choices poised to define the future landscape of the enteric softgel industry.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technological Advancement

Global Enteric Softgel Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Gelatin Softgel Capsules
  • Vegetarian Softgel Capsules

Global Enteric Softgel Market Size by Raw Material & CAGR (2025-2032)

  • Market Overview
  • Type-A Gelatin (Pork Skin)
  • Type-B Gelatin (Animal Bones and Skin)
  • Fish Bone Gelatin
  • Cellulose Derivatives
  • Starch Material

Global Enteric Softgel Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Supermarket and Hypermarket
  • Pharmacy and Drug store
  • Online Provider

Global Enteric Softgel Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Antacid and Antiflatulent Preparations
  • Anti-inflammatory Drugs
  • Antibiotic and Antibacterial Drugs
  • Cough and Cold Preparations
  • Health Supplements
  • Vitamin and Dietary Supplements
  • Other Therapeutic Applications

Global Enteric Softgel Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Cosmeceutical Companies
  • Food Industry

Global Enteric Softgel Market Size & CAGR (2025-2032)

  • North America (Product Type, Raw Material, Distribution Channel, Application, End User)
    • US
    • Canada
  • Europe (Product Type, Raw Material, Distribution Channel, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Raw Material, Distribution Channel, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Raw Material, Distribution Channel, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Raw Material, Distribution Channel, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • BASF SE (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Colorcon Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fuji Capsule Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Now Health Group Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ProCaps Group (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Super Spectrim (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
  • Key Developments
  • Sirio Pharma Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Soft Gel Technologies, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EuroCaps Ltd. (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Geltec Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Captek Softgel International, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elnova Pharma (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Best Formulations (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pharmavite LLC (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Robinson Pharma, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations